Induced pluripotent stem cells as a biopharmaceutical factory for extracellular vesicles.

about

Induced pluripotent stem cells as a biopharmaceutical factory for extracellular vesicles.

Item

http://www.wikidata.org/entity/Q52726126

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Induced pluripotent stem cells as a biopharmaceutical factory for extracellular vesicles.

@en

Induced pluripotent stem cells as a biopharmaceutical factory for extracellular vesicles.

@nl

type

Item

label

Induced pluripotent stem cells as a biopharmaceutical factory for extracellular vesicles.

@en

Induced pluripotent stem cells as a biopharmaceutical factory for extracellular vesicles.

@nl

prefLabel

Induced pluripotent stem cells as a biopharmaceutical factory for extracellular vesicles.

@en

Induced pluripotent stem cells as a biopharmaceutical factory for extracellular vesicles.

@nl

P1476

Induced pluripotent stem cells as a biopharmaceutical factory for extracellular vesicles.

@en

P2093

Hongchao Guo

http://www.w3.org/2001/XMLSchema#string

Masataka Nishiga

http://www.w3.org/2001/XMLSchema#string

P2860

Use of mesenchymal stem cells for therapy of cardiac disease

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine

Exosomes: Fundamental Biology and Roles in Cardiovascular Physiology

Embryonic stem cell-derived cardiac myocytes are not ready for human trials

Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts.

Microfluidic Single-Cell Analysis of Transplanted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes After Acute Myocardial Infarction

Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper.

Potential Strategies to Address the Major Clinical Barriers Facing Stem Cell Regenerative Therapy for Cardiovascular Disease: A Review.

Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics.

P31

scholarly article

P356

10.1093/EURHEARTJ/EHY097

http://www.w3.org/2001/XMLSchema#string

P50

Joseph C Wu

P577

2018-03-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29547885

http://www.w3.org/2001/XMLSchema#string

P932

5963295

http://www.w3.org/2001/XMLSchema#string